Tolnaftate kills many of the fungi responsible for toenail infections, but the drug has a hard time reaching them through the nail plate. That distinction matters more than most over-the-counter labels let on. Tolnaftate is a proven treatment for superficial skin infections like athlete’s foot and jock itch, yet its track record with toenail fungus is far weaker, largely because of a physical barrier rather than a pharmacological one.
How Tolnaftate Attacks Fungal Cells
Tolnaftate belongs to a class of antifungals called thiocarbamates. It works by blocking an enzyme called squalene epoxidase, which fungi need to build ergosterol, a critical component of their cell membranes. Without ergosterol, the fungal cell membrane falls apart. Lab studies confirmed this mechanism decades ago, showing that tolnaftate caused squalene to pile up inside fungal cells while ergosterol production stalled.1PubMed Central. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate This is the same enzyme that terbinafine, the most widely prescribed oral antifungal for nail infections, targets. The shared mechanism is relevant to questions about resistance, which come up later.
In a petri dish, tolnaftate performs well against the dermatophytes that cause the vast majority of toenail infections. It has documented activity against Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis, and several other dermatophyte species.2JAMA Dermatology. Tolnaftate, a Potent Topical Antifungal Agent T. rubrum alone is responsible for roughly 70 to 80 percent of toenail fungal infections worldwide. So on paper, tolnaftate should be a strong candidate. The problem is that “on paper” and “through a toenail” are very different environments.
Why the Nail Plate Changes Everything
Toenails are made of densely packed keratin, and getting a topical drug through that barrier is one of the biggest challenges in treating onychomycosis. A drug can obliterate fungus on a glass slide and still fail clinically if it cannot penetrate the nail in meaningful concentrations. This is the central issue with tolnaftate for toenail use.
A 2024 study directly compared how well various antifungals penetrated human nail clippings in a lab setting. Prescription products like efinaconazole produced large zones of fungal inhibition after passing through nail tissue, while over-the-counter products, including tolnaftate-based ones, showed substantially smaller zones of activity. Against T. rubrum, efinaconazole produced an average inhibition zone of about 82 mm after nail penetration, compared to a range of roughly 10 to 34 mm for the OTC products tested.3PubMed Central. Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison That is not a small gap. The prescription formulations are specifically engineered to move through keratin, while OTC creams and solutions like tolnaftate were designed for skin, not nail.
When those same products were tested without the nail barrier, on cellulose disks, the differences between OTC and prescription options narrowed considerably. This confirms that tolnaftate’s antifungal punch is real, but the delivery problem through nail is severe. Rubbing tolnaftate cream on the surface of a thick, infected toenail delivers only a fraction of the drug to where the fungus actually lives.
What the Evidence Actually Shows for Nail Infections
A Cochrane systematic review that pooled data across many trials found that tolnaftate performs impressively for skin fungal infections. The pooled risk of treatment failure with tolnaftate for skin infections was low, roughly a fifth of the failure rate seen with placebo.4PubMed Central. Systematic review of topical treatments for fungal infections of the skin and nails of the feet That is a strong result, comparable to or better than azole antifungals applied to skin.
For nail infections, though, the picture collapses. The same systematic review noted that trials of topical treatments for toenail fungus showed no significant differences between alternative topical treatments, and the evidence base was described as sparse.4PubMed Central. Systematic review of topical treatments for fungal infections of the skin and nails of the feet In other words, when researchers looked specifically at nails rather than skin, none of the OTC topicals had strong enough evidence to be called clearly effective. The handful of nail trials that existed did not produce convincing results for any OTC agent, tolnaftate included.
This gap between skin and nail effectiveness is not unique to tolnaftate. It reflects a fundamental reality of onychomycosis treatment: topical drugs that work beautifully on exposed skin struggle when the infection is sealed beneath layers of hard keratin. That is why oral antifungals like terbinafine and itraconazole remain the standard of care for moderate-to-severe toenail fungus.
Tolnaftate Compared to Prescription Topicals
If you walk into a pharmacy, you will find tolnaftate sold as Tinactin, Lamisil Defense (not to be confused with the prescription Lamisil oral tablets, which contain terbinafine), and various store brands. These are marketed primarily for athlete’s foot. The FDA-approved prescription topicals for onychomycosis are a different league: efinaconazole (Jublia) and tavaborole (Kerydin) are the two most recent, and ciclopirox nail lacquer (Penlac) has been available longer.
The ex vivo nail penetration data make the comparison stark. Even ciclopirox, the oldest prescription nail lacquer, showed modest penetration compared to efinaconazole and tavaborole. OTC products fell even further behind.3PubMed Central. Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison The prescription options are formulated with penetration-enhancing vehicles designed specifically to carry drug through nail keratin. Tolnaftate cream, by contrast, is formulated to spread on skin.
Even with prescription topicals, complete cure rates for toenail fungus are not spectacular. Clinical trials for efinaconazole report complete cure in roughly 15 to 18 percent of patients after 48 weeks, which sounds discouraging until you compare it to the 3 to 5 percent complete cure rates seen with placebo. Oral terbinafine, taken as a pill for three months, still produces the highest cure rates among standard treatments, often in the range of 35 to 50 percent for complete cure. Tolnaftate applied to nails has not been tested in the rigorous head-to-head trials that would put a number on its cure rate for onychomycosis, which itself says something about where the medical community ranks its usefulness for nails.
The Urea Combination Strategy
One approach that shows more promise for getting tolnaftate into nails involves combining it with urea. High-concentration urea softens and partially dissolves the nail plate, creating a pathway for the antifungal to reach deeper layers. A small clinical study tested daily application of 2% tolnaftate ointment combined with 20% urea ointment under an occlusive dressing in 20 patients with distal onychomycosis. Fourteen of the 20 patients responded to treatment.5PubMed. Treatment of onychomycosis by ODT therapy with 20% urea ointment and 2% tolnaftate ointment The urea did its job first: 17 of the 20 patients developed nail softening, and seven experienced partial nail detachment within a week or two, which then allowed the tolnaftate better access to the infected nail bed.
A 70 percent response rate from a small study is not definitive, but it illustrates the core principle: if you solve the penetration problem, tolnaftate can work on nail fungus. The urea acts as a chemical nail-removal agent, essentially thinning or removing the barrier that stops tolnaftate from doing its job. This approach is more involved than simply painting on a cream. It requires daily occlusive wrapping and managing a nail that is actively softening and potentially separating, which is not something most people are willing to do for months on end without medical supervision.
What Tolnaftate Cannot Treat
Tolnaftate’s antifungal spectrum has a significant gap. It has no meaningful activity against Candida albicans, a yeast that causes a minority but still meaningful percentage of nail infections, particularly in fingernails and in people with chronic mucocutaneous candidiasis.2JAMA Dermatology. Tolnaftate, a Potent Topical Antifungal Agent It also lacks activity against molds like Aspergillus, which can occasionally infect nails, particularly in older adults or people with compromised immune systems. If your nail infection is caused by a non-dermatophyte mold or a yeast, tolnaftate will do nothing regardless of how well it reaches the infection site.
This is one reason dermatologists recommend getting a proper diagnosis before treating toenail fungus. Up to half of nail problems that look like fungal infections are actually something else entirely: psoriasis of the nail, trauma, lichen planus, or simple aging changes. And among confirmed fungal infections, the causative organism matters for treatment selection. Tolnaftate’s strengths are narrow. It hits dermatophytes well but nothing else in the fungal kingdom.
Where Tolnaftate Is Genuinely Useful Around the Feet
Tolnaftate earns its place in the medicine cabinet for what it was designed to do: treating and preventing superficial dermatophyte infections of the skin. For athlete’s foot, the evidence is robust. In one trial comparing tolnaftate cream to tea tree oil and placebo for athlete’s foot, 85 percent of tolnaftate-treated patients converted to negative fungal cultures, compared to 30 percent with tea tree oil and 21 percent with placebo.6Australasian Journal of Dermatology. Tea Tree Oil in the Treatment of Tinea Pedis That is a decisive result.
In a double-blind trial comparing tolnaftate cream to undecylenic acid for dermatophyte skin infections, about 70 percent of patients in the tolnaftate group were cured both clinically and by lab confirmation, compared to roughly 66 percent for undecylenic acid and under 10 percent for placebo.7PubMed. The treatment of dermatophytoses of the glabrous skin: a comparison of undecylenic acid and its salt versus tolnaftate Both active treatments worked well. Tolnaftate had a slight edge but the difference was not dramatic.
This matters for toenail fungus indirectly. Athlete’s foot and toenail fungus are often caused by the same organisms, and untreated athlete’s foot is one of the most common entry points for nail infection. Keeping the skin around your toes clear of dermatophytes with tolnaftate can help prevent new nail infections or reinfection after you have treated an existing one. That preventive role may be the most practical use of tolnaftate in the context of toenail fungus: not curing the nail infection itself, but controlling the surrounding skin reservoir.
Laser Therapy as an Add-On to Topicals
For people committed to avoiding oral medications, combining laser treatment with topical antifungals is an area of growing interest. A systematic review of randomized controlled trials found that combining laser therapy with topical antifungal agents produced significantly better outcomes than topicals alone across several measures, including complete cure rate, fungal clearance, and patient satisfaction.8PubMed. Efficacy of laser therapy combined with topical antifungal agents for onychomycosis: a systematic review and meta-analysis of randomised controlled trials The laser likely works by creating microscopic channels in the nail plate or by directly damaging fungal cells, making it easier for topical medication to reach deeper tissue.
Most of the trials in that review used prescription topicals rather than OTC products, so it is unclear how much benefit laser would add to tolnaftate specifically. But the principle is the same one behind the urea strategy: any method that breaches or thins the nail barrier improves a topical drug’s chances. Laser treatment for nail fungus is not typically covered by insurance and can cost several hundred dollars per session, so it remains a niche option. Still, for someone who cannot tolerate oral antifungals due to liver concerns or drug interactions, the combination of physical nail disruption plus topical treatment is a reasonable conversation to have with a dermatologist.
The Emerging Question of Squalene Epoxidase Resistance
Because tolnaftate and terbinafine both target the same fungal enzyme, squalene epoxidase, rising resistance to one could theoretically reduce the effectiveness of both. Terbinafine resistance has been documented in dermatophytes, particularly in strains of T. rubrum and T. mentagrophytes circulating in parts of South Asia and increasingly in Europe and North America. A 2025 computational analysis identified 14 mutations in the squalene epoxidase gene of resistant dermatophyte strains, most of which destabilized the enzyme’s structure in ways that could alter how drugs bind to it.9Nature. Computational analysis of missense mutations in squalene epoxidase associated with terbinafine resistance in clinically reported dermatophytes
Whether these mutations confer cross-resistance to tolnaftate is not yet well characterized. Tolnaftate and terbinafine bind to squalene epoxidase differently, so resistance to one does not automatically mean resistance to the other. But the possibility exists, and as terbinafine-resistant strains become more prevalent globally, researchers will need to examine whether tolnaftate retains its activity against them. For now, this is a watch-this-space issue rather than a reason to change your treatment decisions. But it does underscore that antifungal options are not infinite, and relying heavily on a single enzyme target carries long-term risks for the effectiveness of the entire drug class.
Safety and Tolerability
Tolnaftate is one of the gentler antifungals on the market. It has been in use since the 1960s and is generally well tolerated with minimal side effects. Occasional skin irritation or mild stinging at the application site is the most common complaint. Allergic contact dermatitis from tolnaftate has been reported in the medical literature, but it is rare enough to warrant individual case reports rather than population-level warnings.10JAMA Network (Archives of Dermatology). Allergic contact dermatitis from tolnaftate
This safety profile is one area where tolnaftate genuinely outperforms the competition. Oral terbinafine, while more effective for nails, carries a risk of liver enzyme elevation and requires blood monitoring in some patients. Oral itraconazole has significant drug interactions. Even prescription topicals like efinaconazole can cause ingrown toenails or local irritation. If you are looking for the lowest-risk antifungal to apply to your feet, tolnaftate is a reasonable choice. It just may not do much for an established nail infection without help breaching the nail barrier.
Practical Advice for Someone Considering Tolnaftate for a Nail Problem
If you have a mildly discolored toenail with a small patch of white or yellow at the tip, and you are not sure whether it is fungus, tolnaftate cream is unlikely to help and could delay getting an actual diagnosis. A dermatologist can clip the nail, send a sample for culture, and tell you what organism is involved. That matters because treatment decisions depend on the causative species, the extent of nail involvement, and whether the infection has reached the nail matrix at the base.
If you have confirmed mild distal nail fungus and want to try something over the counter before committing to prescription treatment, tolnaftate is not the best OTC choice. Mentholated chest rubs (which contain thymol and other compounds with antifungal properties) and undecylenic acid solutions marketed specifically for nails are at least as accessible, and some OTC ciclopirox formulations may offer better nail penetration. None of these are likely to cure moderate or severe nail fungus, but for the most minimal cases, they represent low-cost, low-risk attempts.
Where tolnaftate makes the most sense is as part of a broader foot hygiene regimen. Treating the skin between and around the toes with tolnaftate powder or cream, keeping feet dry, wearing moisture-wicking socks, and alternating shoes to let them dry out all reduce the fungal load in the environment around your nails. For someone who has completed a course of oral antifungal treatment for a nail infection and wants to prevent recurrence, applying tolnaftate to the surrounding skin is a reasonable preventive measure backed by its strong performance against dermatophyte skin infections.